ContraVir Pharmaceuticals

Share on: 
Business Area(s): 
Description: 

ContraVir is developing a portfolio of novel compounds against hepatitis B, including TXL, a highly potent prodrug of the antiviral tenofovir (active component of both Vemlidy® and Viread®)

Career Page(s): 
Location(s): 
ContraVir Headquarters
Edison NJ
United States
Pennsylvania Biotechnology Center
Doylestown PA
United States
Research Facility
Edmonton AB
Canada